ArticleBMC urology2026
Minimally invasive treatment of emphysematous pyelonephritis in diabetic patients: a comparative study.
Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveEmphysematous pyelonephritis (EPN) is a rare but high-mortality infectious disease most commonly seen in diabetic patients, and the timing of percutaneous catheter drainage (PCD) is crucial for its prognosis.
methodsA retrospective analysis was conducted on data of 18 patients diagnosed with diabetes mellitus complicated EPN who were treated in the Urology of the General Hospital of Northern Theater Command between November 2019 and March 2024. The patient cohort was stratified into two groups according to the timing of PCD implementation: the Early PCD group (E-PCD group, n = 11) (≤ 24 h) and the Delayed Salvage PCD group (DS-PCD group, n = 7) (converted to PCD after failure of conservative pharmacotherapy). By comparing of the comprehensive indicators, the clinical value of early PCD was clarified.
resultThe general status recovery time, average hospitalization time, average recovery time, and the recovery time of related infection indicators at multiple sampling time points after treatment in the E-PCD group were significantly shorter than those in the DS-PCD group. The volume change rate of pus cavity of E-PCD was significantly higher than that of DS-PCD group at different unit time periods respectively.
conclusionsCompared with delayed salvage PCD, early ultrasound-guided PCD within 24 h in diabetic patients with EPN can effectively drain pus, quickly control infection symptoms, and accelerate patient recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.